Matsuyama-Yokono_2009_Naunyn.Schmiedebergs.Arch.Pharmacol_379_191

Reference

Title : Chronic inhibition of dipeptidyl peptidase-IV with ASP8497 improved the HbA(1c) level, glucose intolerance, and lipid parameter level in streptozotocin-nicotinamide-induced diabetic mice - Matsuyama-Yokono_2009_Naunyn.Schmiedebergs.Arch.Pharmacol_379_191
Author(s) : Matsuyama-Yokono A , Tahara A , Nakano R , Someya Y , Hayakawa M , Shibasaki M
Ref : Naunyn Schmiedebergs Arch Pharmacol , 379 :191 , 2009
Abstract : Matsuyama-Yokono_2009_Naunyn.Schmiedebergs.Arch.Pharmacol_379_191
ESTHER : Matsuyama-Yokono_2009_Naunyn.Schmiedebergs.Arch.Pharmacol_379_191
PubMedSearch : Matsuyama-Yokono_2009_Naunyn.Schmiedebergs.Arch.Pharmacol_379_191
PubMedID: 18762913

Related information

Citations formats

Matsuyama-Yokono A, Tahara A, Nakano R, Someya Y, Hayakawa M, Shibasaki M (2009)
Chronic inhibition of dipeptidyl peptidase-IV with ASP8497 improved the HbA(1c) level, glucose intolerance, and lipid parameter level in streptozotocin-nicotinamide-induced diabetic mice
Naunyn Schmiedebergs Arch Pharmacol 379 :191

Matsuyama-Yokono A, Tahara A, Nakano R, Someya Y, Hayakawa M, Shibasaki M (2009)
Naunyn Schmiedebergs Arch Pharmacol 379 :191